Are you Dr. Berry?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 37 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
100 Madison Ave
Morristown, NJ 07960Phone+1 973-971-4340- Is this information wrong?
Summary
- Dr. Tymara Berry, MD is a pediatric endocrinologist in Morristown, New Jersey. She is currently licensed to practice medicine in New Jersey.
Education & Training
Icahn School of Medicine at Mount Sinai/Kravis Children'sFellowship, Pediatric Endocrinology, 2006 - 2009
Nicklaus Children's HospitalResidency, Pediatrics, 2003 - 2005
Rutgers New Jersey Medical SchoolClass of 2003
Certifications & Licensure
NJ State Medical License 2009 - 2025
Publications & Presentations
PubMed
- CLO24-079: Results From Phase 3 Trial of Imetelstat, a First-in-Class Telomerase Inhibitor, in Patients With Red Blood Cell Transfusion Dependent (RBC-TD) Non-del(5q) ...Yazan Madanat, Michael R Savona, Mikkael A Sekeres, Uwe Platzbecker, Valeria Santini, Pierre Fenaux, Maria Diez-Campelo, David Valcárcel, Tymara Berry, Souria Doughert...> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
- 6 citationsImetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, ra...Platzbecker, U., Santini, V., Fenaux, P., Sekeres, M., Savona, M., Madanat, Y., Díez-Campelo, M., Valcárcel, D., Illmer, T., Jonášová, A., Bělohlávková, P., Sherman, L...> ;Lancet. 2024 Jan 20
- 16 citationsImetelstat in intermediate-2 or high-risk myelofibrosis refractory to JAK inhibitor: IMpactMF phase III study design.John Mascarenhas, Claire N Harrison, Jean-Jacques Kiladjian, Rami S Komrokji, Steffen Koschmieder, Alessandro M Vannucchi, Tymara Berry, Denise Redding, Laurie Sherman...> ;Future Oncology. 2022 Jul 1
- Join now to see all
